Israel Englander’s Intelligent Bio Solutions INBS Stock Holding History

Israel Englander’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	-$9K	–	7255
2022 Q2	$9K	Sell	6 -6	-50%	-$10.1K	﹤0.01%	6691
2022 Q1	$22K	Buy	+12	New	+$27.6K	﹤0.01%	6622

Other funds holding INBS

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Israel Englander's INBS Position: Q3 2022 in Review

Israel Englander sold out of Intelligent Bio Solutions (INBS) in Q3 2022, closing a stake of 6 shares — an estimated $9K sold.

Israel Englander first reported a position in INBS in Q1 2022 and held it in 2 quarters. The position peaked at $22K in Q1 2022. 8 funds tracked by Wall St. Rank hold INBS as of Q3 2022.

Israel Englander reported no remaining Intelligent Bio Solutions position as of Q3 2022 after selling out during the quarter.
Israel Englander sold 6 Intelligent Bio Solutions shares in Q3 2022, an estimated $9K.
Israel Englander first reported a position in Intelligent Bio Solutions in Q1 2022 and held it in 2 quarters.
Israel Englander's Intelligent Bio Solutions position peaked at $22K in Q1 2022.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.